Explorer
(Source: Poll of Polls)
Debate: Experts share key points after vaccine approval
Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
Pune-based Serum Institute of India has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing 'Covishield', while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for 'Covaxin'.
Serum and Bharat Biotech Pfizer had applied for the accelerated approval on December 6 and 7, respectively.
India
Politics: Suvendu Adhikari Demands CRPF Deployment, Claims Attack During Booth Visit
Election Update: Allegations vs Denial as Bengal Poll Tension Escalates
Breaking: Suvendu Adhikari Claims Attack Near Kalighat, Urges EC Action
Flash: Heated Political Atmosphere in South 24 Parganas During Voting
LATEST BREAKING: TMC-BJP Clash Erupts in Kalighat as Suvendu Adhikari Faces Protest Crowd
View More
Top Headlines
Election
‘Khela Khatam’ To ‘Baseless’: Exit Polls Trigger Political Slugfest Across Parties
Election
What Do Exit Polls Indicate For BJP Across Five States?
Election
Exit Polls In India: From 2004 To 2024, Big Predictions Often Miss The Final Verdict
Election
Tamil Nadu Exit Polls: Vijay Gets Surprise Boost From Axis My India, TVK Predicted To Be The King
Trending News
Ranjit Kumar
Opinion
